171 related articles for article (PubMed ID: 38254184)
1. Safety and efficacy of ketorolac continuous infusion for multimodal analgesia of vaso-occlusive crisis in patients with sickle cell disease.
Pinto VM; Gianesin B; Sardo S; Mazzi F; Baiardi G; Menotti S; Piras F; Quintino S; Robello G; Mattioli F; Finco G; Forni GL; De Franceschi L
Orphanet J Rare Dis; 2024 Jan; 19(1):22. PubMed ID: 38254184
[TBL] [Abstract][Full Text] [Related]
2. Fentanyl Buccal Tablet: A New Breakthrough Pain Medication in Early Management of Severe Vaso-Occlusive Crisis in Sickle Cell Disease.
De Franceschi L; Mura P; Schweiger V; Vencato E; Quaglia FM; Delmonte L; Evangelista M; Polati E; Olivieri O; Finco G
Pain Pract; 2016 Jul; 16(6):680-7. PubMed ID: 26009799
[TBL] [Abstract][Full Text] [Related]
3. A pilot study on the efficacy of ketorolac plus tramadol infusion combined with erythrocytapheresis in the management of acute severe vaso-occlusive crises and sickle cell pain.
de Franceschi L; Finco G; Vassanelli A; Zaia B; Ischia S; Corrocher R
Haematologica; 2004 Nov; 89(11):1389-91. PubMed ID: 15531461
[TBL] [Abstract][Full Text] [Related]
4. Pharmacological interventions for painful sickle cell vaso-occlusive crises in adults.
Cooper TE; Hambleton IR; Ballas SK; Johnston BA; Wiffen PJ
Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742673
[TBL] [Abstract][Full Text] [Related]
5. Acute kidney injury during a pediatric sickle cell vaso-occlusive pain crisis.
Baddam S; Aban I; Hilliard L; Howard T; Askenazi D; Lebensburger JD
Pediatr Nephrol; 2017 Aug; 32(8):1451-1456. PubMed ID: 28238158
[TBL] [Abstract][Full Text] [Related]
6. Effect of ketorolac in pediatric sickle cell vaso-occlusive pain crisis.
Hardwick WE; Givens TG; Monroe KW; King WD; Lawley D
Pediatr Emerg Care; 1999 Jun; 15(3):179-82. PubMed ID: 10389953
[TBL] [Abstract][Full Text] [Related]
7. Early Initiation of Sub-Anesthetic Ketamine Infusion in Adults with Vaso-Occlusive Crises Is Associated with Greater Reduction in Sickle Cell Pain Intensity: A Single Center's Experience.
Kenney MO; Becerra B; Mallikarjunan A; Shah N; Smith WR
Pain Med; 2022 Dec; 23(12):2042-2049. PubMed ID: 35708641
[TBL] [Abstract][Full Text] [Related]
8. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
[TBL] [Abstract][Full Text] [Related]
9. The Risk of Kidney Injury in Patients With Sickle Cell Disease Treated With Ketorolac for Acute Pain.
Harris EM; Oni MO; Donado C; Heeney MM; Solodiuk J; Greco C; Archer NM
J Pediatr Hematol Oncol; 2024 Jul; 46(5):e290-e295. PubMed ID: 38691085
[TBL] [Abstract][Full Text] [Related]
10. Epidural analgesia in the management of severe vaso-occlusive sickle cell crisis.
Yaster M; Tobin JR; Billett C; Casella JF; Dover G
Pediatrics; 1994 Feb; 93(2):310-5. PubMed ID: 8121746
[TBL] [Abstract][Full Text] [Related]
11. Impact of hydroxyurea on hospital stay & analgesic utilization in sickle cell anaemia with vaso-occlusive crises.
Soren UK; Mohanty PK; Meher S; Sukla SK; Hiregoudar M
Indian J Med Res; 2022 Jul; 156(1):122-129. PubMed ID: 36510904
[TBL] [Abstract][Full Text] [Related]
12. Addressing challenges of clinical trials in acute pain: The Pain Management of Vaso-occlusive Crisis in Children and Young Adults with Sickle Cell Disease Study.
Nottage KA; Hankins JS; Faughnan LG; James DM; Richardson J; Christensen R; Kang G; Smeltzer M; Cancio MI; Wang WC; Anghelescu DL
Clin Trials; 2016 Aug; 13(4):409-16. PubMed ID: 27000103
[TBL] [Abstract][Full Text] [Related]
13. Patient-controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease, a randomized controlled trial.
van Beers EJ; van Tuijn CF; Nieuwkerk PT; Friederich PW; Vranken JH; Biemond BJ
Am J Hematol; 2007 Nov; 82(11):955-60. PubMed ID: 17617790
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of pain control with ketorolac tromethamine in patients with sickle cell vaso-occlusive crisis.
Perlin E; Finke H; Castro O; Rana S; Pittman J; Burt R; Ruff C; McHugh D
Am J Hematol; 1994 May; 46(1):43-7. PubMed ID: 7514356
[TBL] [Abstract][Full Text] [Related]
15. Low dose ketamine versus morphine for acute severe vaso occlusive pain in children: a randomized controlled trial.
Lubega FA; DeSilva MS; Munube D; Nkwine R; Tumukunde J; Agaba PK; Nabukenya MT; Bulamba F; Luggya TS
Scand J Pain; 2018 Jan; 18(1):19-27. PubMed ID: 29794277
[TBL] [Abstract][Full Text] [Related]
16. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Biemond BJ; Tombak A; Kilinc Y; Al-Khabori M; Abboud M; Nafea M; Inati A; Wali Y; Kristensen J; Kowalski J; Donnelly E; Ohd J;
Lancet Haematol; 2021 May; 8(5):e334-e343. PubMed ID: 33894169
[TBL] [Abstract][Full Text] [Related]
17. Opioid selection during sickle cell pain crisis and its impact on the development of acute chest syndrome.
Buchanan ID; Woodward M; Reed GW
Pediatr Blood Cancer; 2005 Oct; 45(5):716-24. PubMed ID: 15926170
[TBL] [Abstract][Full Text] [Related]
18. Use of a clinical pathway to improve the acute management of vaso-occlusive crisis pain in pediatric sickle cell disease.
Ender KL; Krajewski JA; Babineau J; Tresgallo M; Schechter W; Saroyan JM; Kharbanda A
Pediatr Blood Cancer; 2014 Apr; 61(4):693-6. PubMed ID: 24249617
[TBL] [Abstract][Full Text] [Related]
19. Tramadol infusion for the pain management in sickle cell disease: a case report.
Erhan E; Inal MT; Aydinok Y; Balkan C; Yegul I
Paediatr Anaesth; 2007 Jan; 17(1):84-6. PubMed ID: 17184440
[TBL] [Abstract][Full Text] [Related]
20. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
[No Abstract] [Full Text] [Related]
[Next] [New Search]
